Ghana must build pharmaceutical sovereignty to secure health future - Minister

To address these constraints, he proposed a five-point industrial agenda that includes strengthening local production of pharmaceutical inputs, establishing a Ghana Pharma Innovation Fund, commercializing university research, developing industry-focused technical skills, enhancing quality standards and expanding government procurement of locally manufactured medicines.” Speaking under the theme, "Advancing Ghana's Pharmaceutical Sovereignty Through Innovation, Requisite Skills Mix and Quality Industrial Value Chain for Economic Transformation," Akandoh said the COVID-19 pandemic exposed the vulnerability of countries that rely almost entirely on imported essential medicines and health products.

Dr Agyekum commended local pharmaceutical manufacturers for their resilience in supplying essential medicines despite operational challenges and said PMAG Day 2026 was designed to showcase the industry's achievements, promote investment opportunities, encourage innovation and stimulate dialogue on positioning Ghana as a competitive pharmaceutical manufacturing hub in Africa.